argenx SE (ARGX) PT Raised to $944 at Citizens After Positive Results in Ocular MG
Tweet Send to a Friend
Citizens analyst Jason Butler raised the price target on argenx SE (NASDAQ: ARGX) to $944.00 (from $925.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
